In his latest Forbes article, Co-Founder Chase Feiger highlights CEO Kevin Conroy's driving ambition to bring an innovative approach to cancers that currently lack screening protocols and transform cancer diagnostics. Learn how this life science organization was willing to risk innovation—and potential failure—with data, conviction, and a little SNL.

Read more >>